Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-18T15:29:29.576Z Has data issue: false hasContentIssue false
  • English
  • Français

Clostridium difficile Among Hospitalized Patients Receiving Antibiotics A Case-Control Study

Published online by Cambridge University Press:  21 June 2016

Scott Modena ,
Dilip Bearelly ,
Kenneth Swartz  and
Frank K. Friedenberg
Scott Modena
Affiliation:
Gastroenterology Section, Temple University Hospital
Dilip Bearelly
Affiliation:
Gastroenterology Section, Temple University Hospital
Kenneth Swartz
Affiliation:
Fox School of Business and Management, Temple University, Philadelphia, Pennsylvania
Frank K. Friedenberg*
Affiliation:
Gastroenterology Section, Temple University Hospital
*
Gastroenterology, Temple University Hospital, 8 Parkinson Pavilion, 3401 North Broad Street, Philadelphia, PA 19140., friedfk@tuhs.temple.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

Clostridium difficile is the most common cause of infectious nosocomial diarrhea and can be found in up to 30% of asymptomatic hospitalized patients. Our primary aim was to compare the clinical characteristics of hospitalized patients who received antibiotics and developed C. difficile-associated diarrhea (CDAD) with those of hospitalized patients who received antibiotics and did not develop the disease.

Design:

Case-control study comprising inpatients at a single institution.

Patients:

Case-patients were defined as patients who had diarrhea and tested positive for C. difficile. Control-patients (matched 4:1 to case-patients) were defined as patients who received antibiotics for at least 5 days and did not develop CDAD.

Results:

On univariate analysis, nine variables were associated with CDAD. Only three of the variables, need for intensive care, length of stay, and macrolide antibiotic use, were found to be significant (P < .05) on logistic regression analysis. The odds ratios for status as a CDAD case were 3.68 (CI95, 1.44 to 9.40) for stay in the intensive care unit and 1.03 (CI95, 1.02 to 1.05) for each day of hospital stay. Receipt of macrolide antibiotics reduced risk significantly; the odds ratio was 0.23 (CI95, 0.19 to 0.87).

Conclusions:

We identified need for intensive care and length of stay as important risk factors for the development of CDAD. We also identified macrolide antibiotic use as protective against its development. Patients receiving intensive care may represent a population to study for targeted prophylaxis.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 8 , August 2005 , pp. 685 - 690
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Fekety, R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997;92:739–750.Google ScholarPubMed
2.Mcfarland, L, Surawicz, C, Greenberg, R, et al.A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271:1913–1918.Google ScholarPubMed
3.Bartlett, JG. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334–339.CrossRefGoogle ScholarPubMed
4.Thomas, C, Stevenson, M, Riley, T. Antibiotics and hospitalized-acquired Clostridium difficile-associated diarrhea: a systemic review. J Antimi-crob Chemother 2003;51:1339–1350.CrossRefGoogle Scholar
5.Buchner, A, Sonnenberg, A. Medical diagnoses and procedures associated with Clostridium difficile colitis. Am J Gastroenterol 2001;96:766–772.CrossRefGoogle ScholarPubMed
6.Buchner, A, Sonnenberg, A. Epidemiology of Clostridium difficile infection in a large population of hospitalized US military veterans. Dig Dis Sci 2002;47:201–207.CrossRefGoogle Scholar
7.Dial, S, Alrasadi, K, Manoukian, C, et al.Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case control studies. CMAJ 2004;171:33–38.CrossRefGoogle ScholarPubMed
8.Barbut, F, Petit, JC. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect 2001;7:405–410.CrossRefGoogle ScholarPubMed
9.Aziz, EE, Ayis, S, Gould, FK, et al.Risk factors for the development of Clostridium difficile toxin-associated diarrhea: a pilot study. Pharma-coepidemiol Drug 2001;10:303–308.CrossRefGoogle ScholarPubMed
10.Mcfarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and Clostridium difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678–684.CrossRefGoogle Scholar
11.Guyot, A, Rawlins, M, Barrett, S. Clarithromycin appears to be linked with Clostridium difficile-associated diarrhea in the elderly. J Antimi-crob Chemother 2000;46:642–643.CrossRefGoogle ScholarPubMed
12.Starr, J, Martin, H, McCoubrey, J, et al.Risk factors for Clostridium difficile colonization and toxin production. Age Ageing 2003;32:657–660.CrossRefGoogle ScholarPubMed
13.Schwaber, MJ, Simhon, A, Block, C, et al.Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000;19:9–15.CrossRefGoogle ScholarPubMed
14.Cunningham, R, Dale, B, Undy, B, et al.Proton pump inhibitors as a risk factor for Clostridium difficile diarrhea. J Hosp Infect 2003;54:243–245.CrossRefGoogle Scholar
15.Kyne, L, Sougioultzis, S, Mcfarland, L, et al.Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002;23:653–659.CrossRefGoogle Scholar
16.Bliss, DZ, Johnson, S, Savik, K, et al.Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding. Ann Intern Med 1998;129:1012–1019.CrossRefGoogle ScholarPubMed
17.El-Serag, HB. Barrett's esophagus, hiatal hernia, and logistic regression analysis. Am J Gastroenterol 1999;94:3395–3396.CrossRefGoogle ScholarPubMed
18.Peduzzi, P, Concato, J, Kemper, E, et al.A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373–1379.CrossRefGoogle ScholarPubMed
19.Wilcox, M. Clarithromycin and risk of Clostridium difficile-associated diarrhea. J Antimicrob Chemother 2001;47:358–359.CrossRefGoogle Scholar
20.Kyne, L, Warny, M, Qamar, A, et al.Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390–397.CrossRefGoogle ScholarPubMed
21.Elmer, GW, Surawicz, CM, McFarland, LV. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870–876.CrossRefGoogle ScholarPubMed